» Articles » PMID: 12765743

Distinguishing Between First-admission Schizophreniform Disorder and Schizophrenia

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2003 May 27
PMID 12765743
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The validity of schizophreniform disorder remains controversial. Past research suggests that cases of schizophreniform disorder may be: (1). atypical cases of affective disorders, (2). cases of schizophrenia in early course, or (3). a heterogeneous group of disorders including a subgroup with benign course and outcome which maintains this diagnosis in the long term.

Method: We tested the validity of the schizophreniform disorder diagnosis by comparing the socio-demographic and baseline clinical characteristics, 24-month course and outcome, and 6- and 24-month research diagnoses of 34 cases initially diagnosed with schizophreniform disorder, and 128 cases with schizophrenia, drawn from a cohort of 628 first-admission patients in the Suffolk County Mental Health Project.

Results: Compared to patients with schizophrenia, those with schizophreniform disorder were more likely to remit fully by 6 months and retain this status by 24 months. Only about half of the patients with schizophreniform disorder were re-diagnosed with schizophrenia or schizoaffective disorder at 24-month follow-up, 13% were re-diagnosed with affective disorders and 19% retained the diagnosis of schizophreniform disorder. In contrast, 92% of cases with a baseline diagnosis of schizophrenia retained this diagnosis at 24-month follow-up. The findings were similar in comparisons with schizophrenia patients having onset of symptoms within 6 months of hospitalization.

Conclusions: Schizophreniform disorder is a heterogeneous category, which includes a small group with benign psychotic disorders who maintain this diagnosis over at least 24 months. Better delineation of this subgroup has important treatment implications.

Citing Articles

Acute Schizophrenia-like Psychotic Disorder Against the Background of COVID-19.

Bravve L, Kaydan M, Kostyuk G Medicina (Kaunas). 2025; 61(2).

PMID: 40005415 PMC: 11857278. DOI: 10.3390/medicina61020298.


Effectiveness of community-based interventions for patients with schizophrenia spectrum disorders: a study protocol for a systematic review.

Kim S, Kim A Syst Rev. 2021; 10(1):106.

PMID: 33845902 PMC: 8042964. DOI: 10.1186/s13643-021-01662-0.


Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis.

Murrie B, Lappin J, Large M, Sara G Schizophr Bull. 2019; 46(3):505-516.

PMID: 31618428 PMC: 7147575. DOI: 10.1093/schbul/sbz102.


Diagnostic shifts during the decade following first admission for psychosis.

Bromet E, Kotov R, Fochtmann L, Carlson G, Tanenberg-Karant M, Ruggero C Am J Psychiatry. 2011; 168(11):1186-94.

PMID: 21676994 PMC: 3589618. DOI: 10.1176/appi.ajp.2011.11010048.


Employment predictors for discharged schizophrenia patients.

Honkonen T, Stengard E, Virtanen M, Salokangas R Soc Psychiatry Psychiatr Epidemiol. 2007; 42(5):372-80.

PMID: 17492406 DOI: 10.1007/s00127-007-0180-5.